Modulating Human Microbiome Function to Enhance Immune Responses Against Cancer (R21 Clinical Trial Not Allowed)
Key Information
Due Date: January 7, 2025
Agency: U.S. Department of Health and Human Services (HHS)
Source: Federal
Funding Category:
Health & Human Services
Funding Amount: $581,371
Funding Type: Grant
Match Required: No
Contact Info:
OERWebmaster03@od.nih.gov
See Section VII. Agency Contacts within the full opportunity announcement for all other inquires.
Overview
Applicants should focus their submissions on determining how the host interacts with specific microbes (or groups of microbes) or their metabolic by-products. These should aim at the manipulation of immune responses in order to augment or prevent inflammation-related or irregular tumor formation.
Attention should be given to the degree, scheduling, and span of administered beneficial microbes, as these factors can significantly influence its effectiveness. The grant application should demonstratively address these parameters.
Key Dates
Open Date: November 3, 2021
Application Due Date: January 7, 2025
Estimated Award Date: Not Specified
Additional Details
Eligible Activities
- Research and Development
Eligible Applicants
- State governments
- County governments
- City, village or township governments
- Special district governments
- Independent school districts
- Public and State controlled institutions of higher education
- Private institutions of higher education
- Small businesses